PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
31830633-4	2020	On the other hand beta-stereoselectivity of rhamnosyl trichloroacetimidate donors protected with O-picoloyl groups at remote positions (C-2 and C-3) has been investigated while the glycosylation reactions of 2-O-picoloyl group substituted l-rhamnosyl donor displays predominant beta-stereoselectivity.	trichloroacetamide	44-74	complement C2	Homo sapiens	136-147
27709822-1	2016	A catalytic strategy was developed for asymmetric substitution reactions at sp3 -hybridized carbon atoms by using a chiral alkylating agent generated in situ from trichloroacetimidate and a chiral phosphoric acid.	trichloroacetamide	163-183	Sp3 transcription factor	Homo sapiens	76-79
25609144-2	2015	Trichloroacetamide (TCAcAm) is an emerging nitrogenous DBP, and our previous study found that TCAcAm could induce some changes associated with host-gut microbiota co-metabolism.	trichloroacetamide	0-18	D site albumin promoter binding protein	Mus musculus	55-58
25609144-2	2015	Trichloroacetamide (TCAcAm) is an emerging nitrogenous DBP, and our previous study found that TCAcAm could induce some changes associated with host-gut microbiota co-metabolism.	trichloroacetamide	20-26	D site albumin promoter binding protein	Mus musculus	55-58
20413107-3	2010	Our synthetic schemes involved using an N-trichloroacetylated trichloroacetimidate glucosaminyl donor activated with excess TMSOTf at 0 degrees C for glycosylation at O-3 of galactosyl residues and that of trichloroacetimidate galactosyl donors activated with excess BF(3).OEt(2) to glycosylate either O-3 or O-4 of glucosamine residues.	trichloroacetamide	62-82	immunoglobulin kappa variable 2D-38 (pseudogene)	Homo sapiens	302-312
23795152-2	2009	The di-mu-amidate complex 3 or its enantiomer (ent-3) are the first asymmetric catalysts that allow commercially available, or readily accessible, (E)-2-alkene-1-ols to be transformed to enantioenriched branched allylic aryl ethers upon reaction of their trichloroacetimidate derivatives with phenols.	trichloroacetamide	255-275	solute carrier family 29 member 3	Homo sapiens	47-52
16630598-4	2006	The key step was the 6-O-glycosylation of a easily accessible derivative of beta-D-Galf-(1-->4)-D-GlcpNAc with a beta-D-Galp-(1-->2)-[beta-D-Galp-(1-->3)]-D-Galp donor using the trichloroacetimidate method.	trichloroacetamide	187-207	galanin like peptide	Homo sapiens	123-127
16630598-4	2006	The key step was the 6-O-glycosylation of a easily accessible derivative of beta-D-Galf-(1-->4)-D-GlcpNAc with a beta-D-Galp-(1-->2)-[beta-D-Galp-(1-->3)]-D-Galp donor using the trichloroacetimidate method.	trichloroacetamide	187-207	galanin like peptide	Homo sapiens	147-151
16630598-4	2006	The key step was the 6-O-glycosylation of a easily accessible derivative of beta-D-Galf-(1-->4)-D-GlcpNAc with a beta-D-Galp-(1-->2)-[beta-D-Galp-(1-->3)]-D-Galp donor using the trichloroacetimidate method.	trichloroacetamide	187-207	galanin like peptide	Homo sapiens	147-151
16494487-3	2006	In the synthesis of the DOPA decarboxylase inactivator, alpha-vinyl-m-tyrosine, the new N-PMP trifluoroacetimidate rearranges much more efficiently than the corresponding trichloroacetimidate.	trichloroacetamide	171-191	dopa decarboxylase	Homo sapiens	24-42
16149811-1	2005	[reactions: see text] The glycosylation with trichloroacetimidates derived from different glycopyranoses bearing a nonparticipating group at C-2 was explored in different ionic liquids as solvents.	trichloroacetamide	45-66	complement C2	Homo sapiens	141-144
16122263-5	2005	Here, we report the gram-scale syntheses of both types of epitopes by an approach that utilizes glucosyl trichloroacetimidate donor 2 to first create a beta-glucopyranoside linkage and then epimerizes the C-2 center via an oxidation-reduction sequence that provides an efficient multigram scale route to the beta-mannopyranosides 5, 8, and 15.	trichloroacetamide	105-125	complement C2	Homo sapiens	205-208
14531676-2	2003	COP-Cl catalyzes the rearrangement of (E)-allylic trichloroacetimidates to provide transposed allylic trichloroacetamides of high enantiopurity, a transformation that underlies the first truly practical method for transforming prochiral allylic alcohols to enantioenriched allylic amines and congeners.	trichloroacetamide	50-71	caspase recruitment domain family member 16	Homo sapiens	0-3
14531676-2	2003	COP-Cl catalyzes the rearrangement of (E)-allylic trichloroacetimidates to provide transposed allylic trichloroacetamides of high enantiopurity, a transformation that underlies the first truly practical method for transforming prochiral allylic alcohols to enantioenriched allylic amines and congeners.	trichloroacetamide	102-121	caspase recruitment domain family member 16	Homo sapiens	0-3
12433456-2	2002	Reported is a systematic evaluation of glucosamine phosphates and trichloroacetimidates as glycosylating agents for the efficient construction of beta-(1 --> 6) glucosamine linkages.	trichloroacetamide	66-87	potassium calcium-activated channel subfamily M regulatory beta subunit 1	Homo sapiens	146-153
12204620-4	2002	The alpha-(1-->3)-linkage was formed in considerable amount with galactose mono- and disaccharide trichloroacetimidate donors with C-2 neighboring group participation.	trichloroacetamide	101-121	complement C2	Homo sapiens	134-137
10985728-7	2000	Hydrogenation with Raney Nickel gave 21 from which after removal of the protecting group at C-1a the trichloroacetimidate 25 was prepared.	trichloroacetamide	101-121	endogenous retrovirus group K member 1	Homo sapiens	92-96
10230631-1	1999	5-Thiofucose-containing LeX trisaccharide analogs Gal beta(1,4)[5SFuc alpha(1,3)]GlcNAc-OMe (2) and Gal beta(1,4)[5SFuc beta(1,3)]GlcNAc-OMe (4) were synthesized via 5-thiofucosylation of methyl 2-azido-lactoside derivative 6 by the trichloroacetimidate method.	trichloroacetamide	233-253	fucosyltransferase 4	Homo sapiens	24-27
34672576-3	2021	The beta-(1   2) and beta-(1   4)-glycosidic bonds were synthesized through a combination of NIS/Yb(OTf)3- and TMSOTf-mediated stereoselective glycosylations of thiotolyl, N-phenyltrifluoroacetimidate, and trichloroacetimidate donors.	trichloroacetamide	206-226	immunoglobulin kappa variable 2D-19 (pseudogene)	Homo sapiens	4-15
34672576-3	2021	The beta-(1   2) and beta-(1   4)-glycosidic bonds were synthesized through a combination of NIS/Yb(OTf)3- and TMSOTf-mediated stereoselective glycosylations of thiotolyl, N-phenyltrifluoroacetimidate, and trichloroacetimidate donors.	trichloroacetamide	206-226	immunoglobulin kappa variable 6D-41 (non-functional)	Homo sapiens	21-32
3621238-0	1987	Application of the trichloroacetimidate method to the synthesis of glycopeptides of the mucin type containing a beta-D-Galp-(1----3)-D-GalpNAc unit.	trichloroacetamide	19-39	LOC100508689	Homo sapiens	88-93
3621238-0	1987	Application of the trichloroacetimidate method to the synthesis of glycopeptides of the mucin type containing a beta-D-Galp-(1----3)-D-GalpNAc unit.	trichloroacetamide	19-39	galanin like peptide	Homo sapiens	119-123
3621238-1	1987	Mucin-type O-glycopeptides containing the beta-D-Galp-(1----3)-D-GalpNAc disaccharide core unit, which is also the T-antigenic determinant, were synthesized from D-galactose, 2-azido-2-deoxy-D-galactose, 2-azido-2-deoxylactose, and L-serine precursors by applying the trichloroacetimidate method.	trichloroacetamide	268-288	LOC100508689	Homo sapiens	0-5